Attitudes and Practices Regarding the Use of Methadone in US State and Federal Prisons

Rich, Josiah D.; Boutwell, Amy E.; Shield, David C.; Key, R. Garrett; McKenzie, Michelle; Clarke, Jennifer G.; Friedmann, Peter D.

doi:10.1093/jurban/jti072

Cited by 111 publications

(121 citation statements)

References 33 publications

(39 reference statements)

Supporting

Mentioning

113

Contrasting

Unclassified

Order By: Relevance

“…In addition, although some work suggests that substance abuse treatment directors can provide valid reports of agency practices (Batten et al, 1993,D'Aunno et al, 1995, the validity and reliability of these administrators' reports is unknown. Medication assisted treatment, another evidencebased practice, was not evaluated because it is so uncommon in criminal justice settings (Rich et al, 2005). Finally, respondent burden prevented asking detailed questions about the nature, quality, fidelity, and utilization of evidence-based services.…”

Section: Discussionmentioning

confidence: 99%

Evidence-based treatment practices for drug-involved adults in the criminal justice system

Friedmann

Taxman

Henderson

2007

Journal of Substance Abuse Treatment

153

144

View full text Add to dashboard Cite

OBJECTIVE-To estimate the extent and organizational correlates of evidence-based practices (EBPs) in correctional facilities and community-based substance abuse treatment programs that manage drug-involved adult offenders. RESULTS-Most programs offer fewer than 60% of the specified EBPs to drug-involved offenders. In multiple regression models, offender treatment programs that provided more EBPs were community-based, accredited, and network-connected; with a performance-oriented, non-punitive culture, more training resources; and leadership with a background in human services, a high regard for the value of substance abuse treatment and an understanding of EBPs. METHODS-CorrectionalCONCLUSIONS-The use of EBPs among facility-and community-based programs that serve drug-involved adult offenders has room for improvement. Initiatives to disseminate EBPs might target these institutional and environmental domains, but further research is needed to determine whether such organization interventions can promote the uptake of EBPs.

show abstract

Section: Discussionmentioning

confidence: 99%

Evidence-based treatment practices for drug-involved adults in the criminal justice system

Friedmann

Taxman

Henderson

2007

Journal of Substance Abuse Treatment

153

144

View full text Add to dashboard Cite

show abstract

“…Incarcerated pregnant women may have difficulties gaining access to the medication or be the target of disapproval from prison authorities for receiving it under federal mandate that makes methadone maintenance an entitlement for all pregnant women. 47 Some patients believe that methadone is categorically "bad for the heart" and should be avoided at all costs. In recent case reports, methadone has indeed been correlated with cardiac side effects, among them torsades de pointes and ventricular arrhythmias.…”

Section: What Is the Epidemiology Of Opioid Use During Pregnancy Andmentioning

confidence: 99%

Cocaine and Opioid Use During Pregnancy: Prevalence and Management

Bhuvaneswar¹,

Chang²,

Epstein³

et al. 2008

Prim. Care Companion J. Clin. Psychiatry

View full text Add to dashboard Cite

“…Approximately onethird of inmates resume substance abuse within the first two months of their release, and 95% of those incarcerated for drug crimes return to drug use within three years of their release (Marlowe, 2003). An estimated 20% of prison inmates have a history of injection drug use, and approximately 24-36% of all heroin addicts, or over 200,000 individuals, pass through the US criminal justice system each year (Rich et al, 2005).…”

Section: Introductionmentioning

confidence: 99%

“…Buprenorphine is a partial opioid agonist (often coformulated with naloxone, an opioid antagonist that precipitates withdrawal if injected) that has also been used to treat opioid dependence. Both buprenorphine and methadone are examples of medication-assisted treatment (MAT) for opioid abuse, and both are effective in reducing heroin and prescription opioid abuse as well as criminal behavior, HIV risk behaviors, and overdose deaths associated with opioid abuse (Nunn et al, 2009;Rich et al, 2005;Zaller et al, 2009). …”

Section: Introductionmentioning

confidence: 99%

“…Some state and federal prisons permit MAT for opioid-dependent prisoners, but the US criminal justice system has generally been reluctant to accept MAT (Magura et al, 2009;McMillan and Lapham, 2005;Nunn et al, 2009;Rich et al, 2005;Westermeyer, 2000). In 1999, a 202-court survey found that 39% of drug courts made methadone available to participants (Peyton and Gossweiler, 2001).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Medication assisted treatment in US drug courts: Results from a nationwide survey of availability, barriers and attitudes

Matusow

2012

Journal of Substance Abuse Treatment

View full text Add to dashboard Cite

Drug treatment courts are an increasingly important tool in reducing the census of those incarcerated for non-violent drug offenses; medication assisted treatment (MAT) is proven to be an effective treatment for opioid addiction. However, little is known about the availability of and barriers to MAT provision for opioid-addicted people under drug court jurisdiction. Using an online survey, we assessed availability, barriers, and need for MAT (especially agonist medication) for opioid addiction in drug courts. Ninety-eight percent reported opioid-addicted participants, 47% offered agonist medication (56% for all MAT including naltrexone). Barriers included cost and court policy. Responses revealed significant uncertainty, especially among non-MAT providing courts. Political, judicial and administrative opposition appear to affect MAT's © 2012 Elsevier Inc. All rights reserved. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. inconsistent use and availability in drug court settings. These data suggest that a substantial, targeted educational initiative is needed to increase awareness of the treatment and criminal justice benefits of MAT in the drug courts. NIH Public Access

show abstract

Attitudes and Practices Regarding the Use of Methadone in US State and Federal Prisons

Cited by 111 publications

References 33 publications

Evidence-based treatment practices for drug-involved adults in the criminal justice system

Evidence-based treatment practices for drug-involved adults in the criminal justice system

Cocaine and Opioid Use During Pregnancy: Prevalence and Management

Medication assisted treatment in US drug courts: Results from a nationwide survey of availability, barriers and attitudes

Contact Info

Product

Resources

About